Track Your Mounjaro Protocol

Mounjaro is the most effective approved GLP-1 medication for weight loss, targeting both GIP and GLP-1 receptors.

Generic Name

Tirzepatide

Manufacturer

Eli Lilly

Mechanism

Dual GIP/GLP-1 receptor agonist

Approved For

Type 2 diabetes

Typical Weight Loss

18-22%

Dosing Frequency

Once weekly injection

Why Track with DoseCurve?

✓Log every injection with visual body map
✓Track weight with dose-colored charts
✓See your estimated blood levels in real-time
✓Compare progress to clinical trial data
✓Smart reminders based on your schedule

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.